Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1898 USD | +1.88% | +3.89% | +30.54% |
04-03 | North American Morning Briefing : Powell Awaited -2- | DJ |
03-28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 31/12/08 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 31/10/12 |
Robert Beardsley
FOU | Founder | 63 | 31/12/08 |
Chris Degnan
DFI | Director of Finance/CFO | 44 | 20/10/19 |
Jennifer Stacey
CMP | Compliance Officer | 59 | 11/10/21 |
Andie Collier
LAW | General Counsel | - | 31/07/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 31/12/08 |
Michael Powell
CHM | Chairman | 69 | 27/11/16 |
Kevin Lokay
BRD | Director/Board Member | 67 | 28/02/19 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 31/10/12 |
Director/Board Member | 63 | 31/08/18 | |
Linda West
BRD | Director/Board Member | 64 | 30/03/20 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 31/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,392,170 | 40,686,553 ( 74.80 %) | 0 | 74.80 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+30.54% | 10.32M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- GRTX Stock
- Company Galera Therapeutics, Inc.